Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
The updated ICH Q14 guidance by the FDA has raised the bar for product quality expectations in release and stability testing. The 3rd ADC Analytical Development conference, scheduled for Tue, 16 Apr 2024 - Thu, 18 Apr 2024, addresses this evolution. It offers a technical exploration into optimizing physiochemical methods to quantify drug-to-antibody ratio (DAR) and distribution, size and charge variants, bioassays for potency understanding, and impurity assays. Engage with 100+ experts from leading organizations like Daiichi Sankyo, Eli Lilly, and AstraZeneca to gain comprehensive insights for producing high-quality, regulatory-compliant antibody-drug conjugates (ADCs). This event fosters collaboration, addresses analytical challenges, and navigates future regulatory clarity for ADC experts.
[Read on adc-analytical.com](https://adc-analytical.com/)
Since 2017, the MedHealth Summit has revolutionized healthcare innovation in Michigan and Ontario. Mark your calendars for April 16, 2024, for a day packed with inspiring speakers and curated matchmaking—all at no cost to attendees. Join our inclusive healthcare ecosystem and stay tuned for early 2024 registration. Share topic ideas, host matchmaking meetings, or become a sponsor in the meantime.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our